Argitalpenak (30) Ana Rojo Sebastian argitalpenak

2020

  1. Vitamin B6 deficiency in patients with parkinson disease treated with levodopa/carbidopa

    Clinical Neuropharmacology, Vol. 43, Núm. 5, pp. 151-157

2019

  1. Dementia

    Medicine (Spain), Vol. 12, Núm. 74, pp. 4329-4337

  2. Diagnostic and therapeutic protocol of cognitive disturbances in patients with movement disorders

    Medicine (Spain), Vol. 12, Núm. 74, pp. 4376-4380

  3. Elderly patient with dementia: complex therapeutic decisions

    Medicine (Spain), Vol. 12, Núm. 74, pp. 4381-4384

  4. Other degenerative dementias. Dementia with Lewy bodies, dementia in Parkinson's disease, frontotemporal dementia and vascular dementia

    Medicine (Spain), Vol. 12, Núm. 74, pp. 4347-4356

  5. The Spectrum of Movement Disorders in 18-p Deletion Syndrome

    Movement Disorders Clinical Practice

  6. Therapeutic aspects in dementias

    Medicine (Spain), Vol. 12, Núm. 74, pp. 4357-4366

2018

  1. Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome

    Pharmacogenomics Journal, Vol. 18, Núm. 4, pp. 565-577

2017

  1. Association between the rs1229984 polymorphism in the alcohol dehydrogenase 1B gene and risk for restless legs syndrome

    Sleep, Vol. 40, Núm. 12

  2. Beyond cervical lipomas: Myoclonus, gait disorder and multisystem involvement leading to mitochondrial disease

    BMJ Case Reports, Vol. 2017

  3. Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome

    Journal of Neural Transmission, Vol. 124, Núm. 3, pp. 285-291

2016

  1. The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study

    Journal of the Neurological Sciences, Vol. 368, pp. 150-154

2015

  1. Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome

    Journal of Neural Transmission, Vol. 122, Núm. 6, pp. 819-823

  2. Association between Vitamin D receptor rs731236 (Taq1) polymorphism and risk for restless legs syndrome in the Spanish caucasian population

    Medicine (United States), Vol. 94, Núm. 47, pp. e2125

  3. Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Restless Legs Syndrome

    Medicine (United States), Vol. 94, Núm. 34, pp. e1448

2014

  1. The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome

    Sleep Medicine, Vol. 15, Núm. 2, pp. 266-268

2013

  1. Dopamine receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome

    Sleep Medicine

  2. MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome

    Journal of Neural Transmission, Vol. 120, Núm. 3, pp. 463-467

  3. Suicidal ideation in a European Huntington's disease population

    Journal of Affective Disorders, Vol. 151, Núm. 1, pp. 248-258

  4. β-defensin genomic copy number does not influence the age of onset in huntington’s disease

    Journal of Huntington's Disease, Vol. 2, Núm. 1, pp. 107-124